Laurent Camille, Meggetto Fabienne, Brousset Pierre
Service d'Anatomie et Cytologie Pathologiques, CHU Purpan, Université Paul-Sabatier, Toulouse III, F-31300 Toulouse, France.
Hum Pathol. 2008 Jul;39(7):983-93. doi: 10.1016/j.humpath.2008.02.010.
In 1994, Chang et al described a novel herpesvirus in tissues from patients with Kaposi sarcoma, referred to as Kaposi sarcoma herpesvirus or human herpesvirus 8. They used a very sophisticated technique of molecular biology to isolate unknown DNA sequences from Kaposi sarcoma lesions, which were not present in normal tissues. It turned out that these sequences corresponded to a previously unrecognized gamma herpesvirus highly homologous to human herpesvirus 4 (Epstein-Barr virus) and to herpesvirus saimiri. Contrary to Epstein-Barr virus, human herpesvirus 8 is not ubiquitous. The seroprevalence of human herpesvirus 8 varies greatly worldwide, with 1% to 10% of people being infected in developed countries and up to 80% of infected individuals in some areas of sub-Saharan and equatorial Africa. Human herpesvirus 8 is associated with a limited spectrum of tumors, mostly observed in immunodeficient individuals with HIV infection. Beside Kaposi sarcoma and multicentric Castleman disease, human herpesvirus 8 is associated with primary effusion lymphoma, but unlike Epstein-Barr virus, human herpesvirus 8 is not involved in epithelial tumors. Different proteins of the virus can be detected in infected cells. Antibodies against the latent nuclear antigen 1 are available in routine pathology and represent a powerful tool to detect the virus in human tissues. Although Epstein-Barr virus is the most frequent causative agent of lymphomas in immunocompromised individuals, a systematic screening of such tumors with specific antibodies reveals that the implication of human herpesvirus 8 infection is probably underestimated. Recent descriptions of non-Hodgkin lymphoma in endemic areas, solid localizations of primary effusion lymphoma, and posttransplantation lymphoproliferations have expanded the spectrum of human herpesvirus 8-related lymphoproliferative disorders. In this review, we will be presenting an overview of the recent concepts regarding human herpesvirus 8 and related disorders.
1994年,张等人在卡波西肉瘤患者的组织中发现了一种新型疱疹病毒,称为卡波西肉瘤疱疹病毒或人类疱疹病毒8。他们运用了非常复杂的分子生物学技术,从卡波西肉瘤病变组织中分离出正常组织中不存在的未知DNA序列。结果发现,这些序列对应于一种先前未被识别的γ疱疹病毒,与人类疱疹病毒4(爱泼斯坦-巴尔病毒)和猴疱疹病毒高度同源。与爱泼斯坦-巴尔病毒不同,人类疱疹病毒8并非普遍存在。人类疱疹病毒8的血清流行率在全球范围内差异很大,在发达国家,1%至10%的人受到感染,而在撒哈拉以南非洲和赤道非洲的一些地区,感染个体比例高达80%。人类疱疹病毒8与有限的一系列肿瘤相关,主要见于感染HIV的免疫缺陷个体。除了卡波西肉瘤和多中心Castleman病外,人类疱疹病毒8还与原发性渗出性淋巴瘤有关,但与爱泼斯坦-巴尔病毒不同,人类疱疹病毒8不参与上皮性肿瘤。在受感染细胞中可以检测到该病毒的不同蛋白质。针对潜伏核抗原1的抗体可用于常规病理学检查,是检测人体组织中该病毒的有力工具。尽管爱泼斯坦-巴尔病毒是免疫受损个体淋巴瘤最常见的致病因素,但用特异性抗体对这类肿瘤进行系统筛查发现,人类疱疹病毒8感染的影响可能被低估了。最近对流行地区非霍奇金淋巴瘤、原发性渗出性淋巴瘤的实体定位以及移植后淋巴组织增生的描述,扩大了人类疱疹病毒8相关淋巴组织增生性疾病的范围。在这篇综述中,我们将概述关于人类疱疹病毒8及相关疾病的最新概念。